Warren, Annabelle M. http://orcid.org/0000-0002-7287-6162
Grossmann, Mathis
Hoermann, Rudolf
Zajac, Jeffrey D.
Russell, Nicholas
Funding for this research was provided by:
otsuka australia pharmaceutical (IIT 156-419-00250)
national health and medical research council (APP2005300)
Article History
Received: 10 June 2021
Accepted: 27 March 2022
First Online: 21 April 2022
Declarations
:
: Ethics approval has been granted by the Austin Health Human Research Ethics Committee HREC/48055/Austin-2019 (Additional file InternalRef removed: Appendix 1). Written, informed consent will be obtained from all participants, or from an authorised surrogate medicate decision-maker if they are unable to do so themselves.
: Written, informed consent forms required for participation specify that de-identified information from the trial is planned for publication. Copies of the participant information and consent forms are available to interested parties on request.
: MG has received research funding from Bayer, Novartis, Weight Watchers and Lilly and speaker’s honoraria from Besins Healthcare and Otsuka. The other authors declare that they have no competing interests.